Beth Hecht Sells $141K of Xeris Biopharma Holdings Inc (XERS) — SEC Form 4, Sep 01, 2026

Open-Market Net Sale · SEC Form 4

−$141,434

10b5-1 Plan

Equity position changed by -1.5%

Reporting Owner

Beth Hecht

TXN 2026-09-01 · FILED 2026-09-01

Equity Position 1.13M sh 1,144,462 → 1,127,796

Equity Change -1.5% shares held after vs before

Filing Lag 0 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Xeris Biopharma Holdings Inc

XERS CIK 0001867096

Reporting Owner

Name	Relationship
Beth Hecht CIK 0001652410	GC

Beth Hecht at Xeris Biopharma Holdings Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $1,462,369

More from this insider at Xeris Biopharma Holdings Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2	2026-09-01	S - Sale 10b5-1	16,666 D	$8.49	-$141,434	1,127,796	Direct

Footnotes (2)

F1: The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025. Show more
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.390 to $8.600, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Show more